Abbott Laboratories (ABT) Common Equity (2009 - 2026)
Abbott Laboratories (ABT) posted Common Equity of $51.8 billion for Q2 2026, up 3.62% sequentially from $50.0 billion in Q1 2026, and up 6.8% YoY from $48.5 billion in Q2 2025.
Abbott Laboratories (ABT) Common Equity (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Common Equity for 18 years, with the latest figure at $51.8 billion in Q2 2026.
- Quarterly Common Equity rose 6.8% year-over-year to $51.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $51.8 billion (up 6.8% YoY) and the FY2025 annual result came in at $52.8 billion, up 11.66% from the prior year.
- Common Equity climbed to $51.8 billion in Q2 2026 per ABT's latest filing, from $50.0 billion in the prior quarter.
- Over five years, Common Equity peaked at $52.8 billion in Q4 2025 and troughed at $33.3 billion in Q1 2022.
- A 5-year average of $41.6 billion and a median of $38.2 billion in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2025 and 2026: Common Equity soared 31.26% in 2025, then increased 4.7% in 2026.
- Over 5 years, Common Equity stood at $35.3 billion in 2022, then increased by 6.52% to $37.6 billion in 2023, then grew by 25.85% to $47.3 billion in 2024, then climbed by 11.66% to $52.8 billion in 2025, then decreased by 1.91% to $51.8 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $51.8 billion, $50.0 billion, and $52.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | 12.63 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.76 Bn |
| Mar 31, 2026 | 49.96 Bn |
| Dec 31, 2025 | 52.77 Bn |
| Sep 30, 2025 | 51.26 Bn |
| Jun 30, 2025 | 48.47 Bn |
| Mar 31, 2025 | 47.72 Bn |
| Dec 31, 2024 | 47.26 Bn |
| Sep 30, 2024 | 39.06 Bn |
| Jun 30, 2024 | 38.35 Bn |
| Mar 31, 2024 | 38.01 Bn |
| Dec 31, 2023 | 37.55 Bn |
| Sep 30, 2023 | 36.92 Bn |
| Jun 30, 2023 | 36.36 Bn |
| Mar 31, 2023 | 35.87 Bn |
| Dec 31, 2022 | 35.26 Bn |
| Sep 30, 2022 | 35.12 Bn |
| Jun 30, 2022 | 34.49 Bn |
| Mar 31, 2022 | 33.30 Bn |
| Dec 31, 2021 | 31.53 Bn |
| Sep 30, 2021 | 30.38 Bn |